Cancer drug improved cognition, motor skills in small Parkinson's clinical trial An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson's disease and Lewy body dementia in a small phase I clinical trial, report researchers. In addition, the drug, nilotinib (Tasigna by Novartis), led to statistically significant and encouraging changes in toxic proteins linked to disease progression (biomarkers).
Study finds mechanisms of early insulin treatment for diabetes may produce better outcomes A pilot study of 23 adults with newly diagnosed type 2 diabetes found early insulin therapy to be as effective as 15 months of oral therapy and may improve the body's ability to produce insulin.
Sniffing and gasping can prevent fainting Sniffing and gasping can prevent fainting, reveals new research
Stressed dads affect offspring brain development through sperm microRNA Researchers have shown at the molecular level how experiencing stress changes a male mouse's sperm in such a way that it affects his offspring's response to stress. This change is imparted epigenetically, or through a means other than the DNA code, by molecules called microRNAs, or miRsRegrow a tooth? Fish, yes; humans, maybe some day When a Lake Malawi cichlid loses a tooth, a new one drops neatly into place as a replacement. Why can't humans similarly regrow teeth lost to injury or disease?